Chest tube pain relief: new study tests numbing drug after heart surgery
NCT ID NCT07116343
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether giving a numbing medicine (ropivacaine) through chest tubes after heart surgery helps patients recover better than a placebo. About 116 adults having planned heart surgery will take part. The goal is to see if this approach reduces pain and improves overall recovery without major side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Primorskiy general hospital #1
RECRUITINGVladivostok, Russia
-
Saint-Petersburg university hospital
RECRUITINGSaint Petersburg, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Could continuing a common heart drug before surgery save lives?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts โ a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?